Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay. The Yourgene Cystic Fibrosis Base assay is a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment.
Black cancer survivors face higher risk of cardiovascular disease
A new study from researchers at the American Cancer Society (ACS) found that Black cancer survivors in the United States experience a higher risk of
July 20, 2023